The QMN Weekly Bulletin

Hospira, CSL Biotherapies Recall Drugs on Manufacturing Issues

April 20, 2012
A A
Hospira is recalling one lot of its morphine sulfate injection and CSL Biotherapies is recalling a number of batches of an albumin intravenous solution after both companies found manufacturing irregularities. Hospira’s recall involves one lot of its morphine sulfate injection delivered in a Carpuject syringe system. The recall comes after a customer report that two Carpuject syringes contained more than the appropriate fill volume.
Drug Industry Daily